Streptococcus parasuis, an Emerging Zoonotic Pathogen, Possesses the Capacity to Induce Cerebral Inflammatory
Kexin Qi1, Xueli Yi2, Mingliu Wang3
1State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Abstract:
To date, three Streptococcus parasuis strains, BS26, BS27, and NN1, have been isolated from the blood cultures of patients with peritonitis, pneumonia, and arthritis, indicating that S. parasuis is an emerging threat to susceptible people. There is thus an urgent need to further evaluate the pathogenesis of S. parasuis clinical strains in order to design efficient anti-inflammatory strategies. Our previous study demonstrated the capacity of S. parasuis clinical strains to enter the central nervous system (CNS) of infected mice. However, the characteristics and inflammatory mechanism of CNS infections caused by S. parasuis are still non-available. In the present study, we investigated the proportion and time of two clinical S. parasuis strains NN1 and BS26 infected mice that developed neurological symptoms. The characteristics of histopathological changes and the cerebral immune response in mice with neurological symptoms were analyzed. Furthermore, we evaluated the roles of microglia and astrocytes in the S. parasuis clinical strain-induced cerebral inflammation. Our data indicated that S. parasuis clinical strains possess a high potential to induce cerebral inflammation in susceptible people at the early phase of infection. Our study contributes to increasing the understanding of the pathogenicity of S. parasuis and the inflammatory mechanisms of the brain against infection caused by S. parasuis.
Insights
Streptococcus parasuis clinical strains can infect the central nervous system, causing neurological symptoms and cerebral inflammation. This study investigates their pathogenic potential and brain inflammatory mechanisms.
Area of Science:
- Microbiology
- Immunology
- Neurology
Background:
- Streptococcus parasuis is an emerging pathogen causing peritonitis, pneumonia, and arthritis.
- Clinical S. parasuis strains have demonstrated the ability to enter the central nervous system (CNS).
- Understanding the pathogenesis and CNS inflammatory mechanisms of S. parasuis is crucial for developing treatments.
Purpose of the Study:
- To investigate the neurological symptoms and cerebral inflammation induced by S. parasuis clinical strains NN1 and BS26 in mice.
- To analyze the histopathological changes and cerebral immune responses in infected mice.
- To evaluate the roles of microglia and astrocytes in S. parasuis-induced cerebral inflammation.
Main Methods:
- Infection of mice with S. parasuis clinical strains NN1 and BS26.
- Monitoring for neurological symptoms and determining their onset.
- Histopathological examination of brain tissues.
- Analysis of cerebral immune responses, including glial cell activation.
Main Results:
- S. parasuis clinical strains NN1 and BS26 induced neurological symptoms in infected mice.
- Histopathological analysis revealed significant changes in the brain.
- Activation of microglia and astrocytes was observed, indicating a cerebral immune response.
- S. parasuis clinical strains show a high potential for inducing early-phase cerebral inflammation.
Conclusions:
- S. parasuis clinical strains can cause CNS infections and neurological symptoms.
- These bacteria possess a significant potential to induce cerebral inflammation early in the infection process.
- The study enhances understanding of S. parasuis pathogenicity and brain inflammatory responses to infection.
More Related Videos
Related Concept Videos
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis ll: Pathophysiology
Brain Abscess l: Introduction


